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Objective: The aim of this work was to evaluate the lymphocyte immunophenotype in an
elderly population.
Methods: This study enrolled 35 over 60-year-old volunteers and a control group composed of
35 young adults. The study included elderly without diseases that might affect the function-
ing of the immune system. These individuals were consulted by doctors and after a physical
examination, laboratory tests were performed using a Beckman Coulter® ﬂow cytometer.
The GraphPad Prism computer program was employed for statistical analysis with the level
of signiﬁcance being set for p-values <0.05.
Results: There is a statistically signiﬁcant reduction in the number of lymphocytes (CD8+,
CD2+ and CD3+ cells) in the elderly compared to young adults. These low rates are explained
by changes attributed to aging andmay be partly responsible for the reduction in the cellular
immune response, lower proliferative activity and the low cytotoxicity of lymphocytes.
Conclusion: These parameters showed greater impairment of adaptive immunity in the
elderly population and can therefore explain the greater fragility of the aged body to devel-
oping diseases.© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
The innate immune system consists of several components.Introduction
The immune system is our ﬁrst line of defense against for-
eign agents. These invaders, viruses, bacteria and fungi, can
be moderately aggressive, such as those responsible for the
common cold or more harmful such as in meningitis or tuber-
culosis. However, this system has several internal control
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reserved.mechanisms that prevent the development of infections. The
defense mechanisms range from mechanical protection to
complex cellular and molecular mechanisms.1
Innate immunity acts as a ﬁrst line of organism defense.0-060 Crato, CE, Brazil.
First, the epithelial barrier prevents infections and if this
defense is destroyed, a group of phagocytic cells are activated,
including monocytes, macrophages and neutrophils.2
e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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In addition, the immune system can elicit another type of
esponse called the adaptive immune system, which is also
ffective but slower and longer lasting. Its main characteris-
ics are immune memory and speciﬁcity. In acquired immune
esponses, lymphocytes, classiﬁed into two basic categories as
lymphocytes and B lymphocytes, act to destroy pathogens.3
With aging, the elderly are affected more by infections and
re more likely to develop cancer than younger individuals.
hese clinical problems are attributed, at least in part, to the
ging of the immune system, immunosenescence, which is
ssociated with an imbalance in the immune function.4
One theoretical basis to explain the aging process is that
he immune activity, similar to most other physiological func-
ions, declines with age.5 Conversely, studies have shown that
here is an increase of natural killer (NK) cells with increas-
ng age. The real cause of this increase remains unknown, but
t is believed that this compensates for the decline in T-cell
esponse.6
Neutrophils, important cells of innate immunity, do not
espond efﬁciently in the mobilization process of the elderly
hen the hematopoietic system is under stress, for example,
uring chemotherapy and in severe prolonged infections. In
hese circumstances, the process of migration of neutrophils
rom the bone marrow into the systemic circulation is not as
ctive as in youth people.7 Moreover, studies with different
ge groups demonstrated a signiﬁcant decline in the phago-
ytic ability of neutrophils against bacteria as well as in the
umber of bacteria engulfed with advancing age.8
Research has shown that aging is accompanied by progres-
ive changes in the composition of lymphocyte subsets (CD4
nd CD8) in lymphoid tissues, with changes associated to T-
ell function including those in relation to cytokine secretion.6
One of the major changes in the immune response in
espect to the senescence system is the reduction of virgin
cells and increase in memory clones, in other words, CD4+
nd CD8+ memory T cells expand while CD4+ and CD8+ virgin
cells gradually decrease with aging.9
An evaluation of the immune system may help to develop
nterventions in the elderly to avoid health problems that
ould eventually affect the independence of these individ-
als. Thus, early treatment may revert damage that under
ther circumstances would become irreversible.10
bjective
he aim of this study was to evaluate the proﬁle of the normal
ymphocyte immunophenotypes in a population of healthy
lderly people.
ethods
his research is a descriptive study of lymphocyte
mmunophenotyping in an elderly population. Therefore,
articipants should be at least 60 years old and as healthy as
ossible.Interviewers visited more than 200 homes to ascertain
hether any of the residents were over 60 years old. They
xplained the purpose of the research and invited those who
ere interested to participate in the study.14;36(3):180–183 181
The study groupwas selected by theGeriatricsDepartment,
University Hospital Walter Cantídio (UHWC) of the Univer-
sidade Federal do Ceará (UFCE). For the physical evaluation,
physicians requested basic biochemical tests, including com-
plete blood count, total cholesterol, triglycerides, blood sugar,
and creatinine in order to better assess each individual. After
this evaluation, the study enrolled 35 of 200 elderly, who
were physically healthy and had normal results for all these
exams.
Informed consent was obtained from all participants and
the study was approved by the Research Ethics Committee of
the UFCE.
Thus, the population consisted of 61- to 92-year-old indi-
viduals of both genders and without chronic diseases, such
as rheumatoid arthritis and systemic lupus erythematosus.
Moreover the participants did not have acute infections such
as colds and viruses, mental disability or had been diagnosed
with depressive syndrome.
Individuals with autoimmune diseases, or other problems
that may impair the immune system and those suffering from
renal failure, severe heart disease or anemia were excluded
from the study. Other exclusion criteria were the use of corti-
costeroids or immunosuppressive medications.
A control group of randomly chosen young adults was also
createdmainly of companions of patientswhowerewaiting to
be consulted at HUWC. Controls were submitted to the same
tests as the study group and only those with normal results
were enrolled in the study.
Blood samples were collected by venipuncture using sterile
disposable equipment in a tube with 5mL of ethylenedi-
aminetetraacetic acid (EDTA) as anticoagulant. This sample
was used to perform immunophenotyping (markers of lym-
phocytes) with all tests being carried out on the same day the
blood was drawn to guarantee the results.
The investigation of the immunophenotype was made
using a Beckman Coulter® ﬂow cytometer to obtain counts
and percentages of the subpopulations of lymphocytes.
Following themanufacturer’s instructions, 100mLofwhole
blood were incubated for 15minutes with a combination of
labeled monoclonal antibodies (10mL each) in the dark at
room temperature. Monoclonal antibodies, of the same brand
as the ﬂow cytometer, were conjugated with speciﬁc ﬂuo-
rochromes. After incubation, the samples were subjected to
lysis using a standard reagent (OptiLyse® C).
Cells with the different markers (CD3, CD4, CD8, CD2,
CD19)were counted using a technique that has been described
previously11. Data are reported as absolute numbers and per-
centages.
The GraphPad Prism computer program (version 5.0) was
used for statistical analysis. The Mann–Whitney test was
employed for nonparametric values and Student’s t-test for
parametric values, with the level of statistical signiﬁcance for
all tests being set for p-values <0.05.
ResultsTables 1 and 2 show the absolute and relative numbers (per-
centages) and other data of lymphocytes in the Study and
Control Groups.
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Table 1 – Lymphocytes analyzed by ﬂow cytometry.
Young people (n=35) Elderly (n=35) p-Value
CD4
% 43.41 ± 10.58 41.47 ± 10.34 0.4417
Count 838.5 ± 374.8 779.7 ± 435.8 0.1569
CD19
% 11.58 ± 3.91 10.56 ± 4.93 0.3401
Count 222.9 ± 103.4 191.4 ± 122.1 0.1253
CD8
% 27.97 ± 7.06 20.67 ± 7.89 <0.0001b
Count 575.9 ± 258.7 417.4 ± 313.4 <0.0001b
CD2
% 80.49 ± 4.27 76.04 ± 7.81 0.0043a
Count 1577 ± 482.6 1485 ± 683.2 0.1587
CD3
% 74.97 ± 5.82 67.41 ± 9.5 0.0002a
Count 1467 ± 456.3 1336 ± 629.8 0.0989
Counts in cells/mm3.
Results are reported as means± standard deviation.
a Student’s t-test.
b Mann–Whitney test.
The percentages of the lymphocytes with the CD8+, CD2+,
and CD3+ markers were signiﬁcantly lower in the group of
elderly than in the young adult control group. Moreover the
absolute number of lymphocytes with the CD8+ marker was
signiﬁcantly lower in the elderly than in young adults.
Discussion
The present study evaluated the immunophenotype of lym-
phocytes to identify possible changes that accompany aging.
Adecrease in the relativenumbers of cells expressing theCD2+
and CD3+ markers were observed in the elderly compared to
young individuals. Moreover, decreases in both relative and
absolute numbers were seen for lymphocytes with the CD8+
marker.
The absolute values (cells/mm3) are calculated indirectly
from the value obtained for the total lymphocyte count
and the percentage for each of the different subpopulations.
It is known that absolute values of subpopulations char-
acterize the biological condition of each individual better
than the total lymphocyte count. It is also known that the
Table 2 – Values of the surface markers of lymphocytes.
Young people (n=35)
Minimum
value
Maximum
value
Mean Median
CD2 69.8 86.7 80.49 80.8
CD3 34.4 36.0 74.97 75.7
CD4 29.0 86.2 43.41 40.5
CD8 17.1 45.8 27.97 26.0
CD19 6.0 20.0 11.58 11.2
Values are shown as percentages.absolute values of lymphocyte subpopulations characterize
the biological condition of each individual better than the rel-
ative values (percentages) and so these are used in the clinical
practice.
TheworkofMazari andLesourd in 1998,whichevaluated11
healthy elderly people, found a mean count of 1957 cells/mm3
and 91.5% for CD2+ lymphocytes.12 In this study, the mean
count was 1485 cells/mm3 and 76.04% for the elderly group.
This difference may be due to several factors, for example,
the monoclonal antibodies used or because the population
samples are from different regions.
We found no studies that show statistically signiﬁcant dif-
ferences for the percentages of the different subpopulations
of lymphocytes in elderly subjects compared to young adults.
A study of the elderly by Sansoni et al.13 in 2008 evaluated
lymphocyte subpopulations and found a drop in the abso-
lute number of CD3+, CD4+ and CD8+ cells. In relation to our
study, lower values in the absolute number of lymphocytes
+were found only in the subpopulation of CD8 cells. Perhaps,
if the study had a larger study sample a statistically signiﬁ-
cant difference may also have been found for CD3+ cells as
the p-value (0.0989) was close to the cut-off of 0.05.
Elderly (n=35)
Minimum
value
Maximum
value
Mean Median
62.2 89.8 76.04 76.9
34.4 34.6 67.41 68.2
26.5 65.0 41.47 39.5
11.5 42.1 20.67 17.1
3.9 22.8 10.56 8.9
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Lesourd and Conde-Martins14 reported that a drop in
D8+ lymphocytes, even though modest, is signiﬁcantly more
mportant than a drop in CD4+ cells.
onclusion
decrease of immune cells was observed in healthy elderly
eople compared with young adults, especially in relation
o lymphocytes with the CD8 phenotype. Thus, the lower
umbers of lymphocytes in the elderly may affect the body’s
efenses and simple illnesses such as viruses may have seri-
us consequences in this population. These values might
erve as a reference for the normal aged population in our
egion.
These results show greater impairment of adaptive immu-
ity in the elderly and may well justify a greater fragility of the
lderly to diseases such as cancer.
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